Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Is Predicted to Exhibit Remarkable Growth by 2032 | Key Companies – Processa Pharma, OnQuality Pharma, and Others

Delveinsight Business Research LLP
DelveInsight’s “Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Hand-Foot Syndrome Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Hand-Foot Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: An Overview

Palmar-plantar erythrodysesthesia (PPE), also called a hand-foot syndrome, is a relatively common dermatologic toxic reaction associated with cytotoxic chemotherapy that can limit the use of such drugs.

Painful red swelling of the feet and hands in a patient receiving chemotherapy suggests the diagnosis. A high degree of suspicion is the key to diagnosis in patients receiving chemotherapeutic agents. The problem may also occur in patients with bone marrow transplants, as the clinical and histologic features may mimic cutaneous infestations of graft-versus-host disease.

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Key Facts

According to DelveInsight’s findings, males are affected more as compared to females, in the case of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome.

According to V. Nikolaou et al., the incidence of PLD-associated HFS is up to 50% for any grade reactions and approximately 20% for patients with grade 3. HFS is rare with bolus 5-FU infusion, whereas it is much more common with continuous infusion (34% vs. 13%). 

As per a study conducted by Paulo M. Hoff et al., Twenty-eight (68.3%) of the 41 patients had at least one episode of HFS. Most patients had their first (92.9%) or most severe (67.9%) episode of HFS within the first two cycles of treatment.

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market

Hand-Foot Syndrome Market is expected to grow in the coming years owing to the increasing prevalent population and the expected launch of emerging drugs.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Hand-Foot Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Hand-Foot Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology Segmentation

Diagnosed Cases of Hand-Foot Syndrome

Total Incident Cases of Hand-Foot Syndrome

Treatable Cases of Hand-Foot Syndrome

Grade-specific Incident Cases of Hand-Foot Syndrome

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hand-Foot Syndrome market or expected to get launched during the study period. The analysis covers Hand-Foot Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hand-Foot Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/hand-foot-syndrome-market

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Therapeutics Analysis

The Hand-Foot Syndrome market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the complication, incremental healthcare spending across the world, and the expected launch of emerging therapies.

Some of the key companies in the Hand-Foot Syndrome Market include:

Processa Pharmaceuticals

OnQuality Pharmaceuticals

And many others

Hand-Foot Syndrome Therapies covered in the report include:

PCS6422

OQL033

And many more

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/hand-foot-syndrome-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Competitive Intelligence Analysis

4. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Overview at a Glance

5. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Disease Background and Overview

6. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Patient Journey

7. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology and Patient Population

8. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Unmet Needs

10. Key Endpoints of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment

11. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Marketed Products

12. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Emerging Therapies

13. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Outlook (7 major markets)

16. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Access and Reimbursement Overview

17. KOL Views on the Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market.

18. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Drivers

19. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/hand-foot-syndrome-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

 

Other Trending Healthcare Reports by DelveInsight

Spinal Decompression/Traction Devices Market
“Spinal Decompression/Traction Devices Market” research report provides comprehensive insights into the Spinal Decompression/Traction Devices market size, share, trends as well as the key companies and emerging products in the market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Are you a market researcher?

Explore our research partnership options.

Partnerships

Find out what people like and dislike about your competitors, and compare it with your brand performance.

Competitor Analyzer

Generated by Feedzy
%d bloggers like this: